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a b s t r a c t
Cerebralmalaria (CM) is a severecomplication resulting fromPlasmodiumfalciparum infection. Theunder-
lying mechanisms of CM pathogenesis remain incompletely understood. The imbalance between the
release of proinﬂammatory and anti-inﬂammatory cytokines has been associated with central nervous
system dysfunction found in human and experimental CM. The current study investigated anxiety-like
behavior, histopathological changes and release of brain cytokines in C57BL/6 mice infected with Plas-
modium berghei strain ANKA (PbA). Anxiety-like behavior was assessed in control and PbA-infected miceeywords:
erebral malaria
nxiety-like behavior
levated plus maze
nﬂammatory cytokines
using the elevated plus maze test. Histopathological changes in brain tissue were assessed by haema-
toxylin and eosin staining. Brain concentration of the cytokines IL-1, IL-4, IL-10, TNF- and IFN- was
determined by ELISA. We found that PbA-infected mice on day 5 post-infection presented anxiety symp-
toms, histopathological alterations in the brainstem, cerebrum and hippocampus and increased cerebral
levels of proinﬂammatory cytokines IL-1 and TNF-. These ﬁndings suggest an involvement of central
atorynervous system inﬂamm
alaria is associatedwith at least 2.3million deaths annually, from
n estimated 400 million cases of malaria each year worldwide
28]. Cerebral malaria (CM) is a severe complication resulting from
lasmodium falciparum infection [13].
The underlyingmechanisms of CMpathogenesis remain incom-
letely understood [11,24]. High levels of circulating and cerebral
issue proinﬂammatory cytokines including tumor necrosis factor
TNF)- and interleukin (IL)-1 have been associated with central
ervous system (CNS) dysfunction found inhumanand experimen-
al CM [2,3,14,25].
Overproduction of proinﬂammatory cytokines, especially TNF-
, induces an increase of adhesion molecule expression on
ascular endothelium with subsequent sequestration of leuco-
ytes, parasitized red blood cells (pRBC) and platelets, leading to
icrovascular obstruction and hypoxia [6]. In addition, the release
f anti-inﬂammatory cytokines,mainly IL-10, seems to have a host-
rotective role by regulating the synthesis of proinﬂammatory
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cytokines in response to theparasite. However, this host-protective
mechanism might be deﬁcient in CM disease [12,18]. In this
context, an imbalance in the release of proinﬂammatory and anti-
inﬂammatory cytokines seems to be crucial to the development of
CM [6,18].
Animal models have been of great relevance in the study of
the mechanisms involved in CM pathogenesis [6,27]. Due to the
high degree of reproducibility, easily manageable characteristics
and development of histopathological and neurological signs typi-
cal of human CM, the murine model using the Plasmodium berghei
strain ANKA (PbA) has been widely used to better understand this
condition [24].
Behavioral and neurological symptoms in PbA-infected mice
have been associated with neuroinﬂammatory processes [7,19,20].
However, to the best of our knowledge, no previous study
has investigated the occurrence of anxiety-like behavior asso-
ciated with CNS inﬂammation in CM. Thus, the aim of the
current study was to investigate anxiety-like behavior and
the release of brain cytokines in C57BL/6 mice infected with
Open access under the Elsevier OA license.PbA.
All experimentswere approvedby theAnimal Ethics Committee
of the Federal University of Minas Gerais (UFMG). Female C57BL/6
mice (20–25g), aged 6–8 weeks, were obtained from Animal Care
Facilitiesof the InstituteofBiological Sciences,UFMG.Animalswere
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sig. 1. Anxiety and locomotor measures of PbA-infected mice on day 5 post-infecti
rm entries and (C) closed arm entries. Results were expressed as the mean± SEM
p<0.05.
oused incages in temperature-controlled roomsandreceived food
nd water ad libitum.
Unclonedparasite lineofP. berghei (strainANKA) (PbA)wasused
n this study.P. bergheiANKApRBC fromC57BL/6micedonor strains
eremaintained in stabilized liquid nitrogen andwere thawed and
assed into normal C57BL/6 mice that served afterwards as para-
ite donors. C57BL/6 mice were infected by intraperitoneal (i.p.)
njection of 106 pRBC suspended in 0.2mL PBS [10]. Control ani-
als received the same volume of PBS. The level of parasitemia
n infected mice was monitored on Giemsa-stained blood ﬁlms
rom day 3 onwards and estimated at 1000 RBCs under immersion
il.
Anxiety-like behaviorwas assessed in control and infectedmice
nday5post-infection (p.i.) using the elevatedplusmaze (Insight®,
P, Brazil). Anxiety-like behavior was evaluated on day 5 p.i. in
greementwith previous studies describing the onset of behavioral
ymptoms in CM mice on day 5 after infection with PbA [19,20].
he elevated plus maze (EPM) is a test of unconditioned anxiety-
elatedbehavior that involves a conﬂict between the rodent’s desire
o explore a novel environment and anxiogenic elements such as
levation and an unfamiliar open area [23]. This is a widely used
est for anxiety behavior of rodents [9,23,26]. The EPM test was
onducted as previous described by Walf and Frye [30]. Brieﬂy,
ice were placed in the center of the maze facing an open arm
nd were allowed to freely explore the EPM for 5min. The animal
lacing all four paws onto the arm was considered to be in the
rm, otherwise the animal was in the center of the maze. Behav-
or that was recorded when rodents were in the EPM included the
ime spent and entries made on the open and closed arms. The
easures of anxiety were the percentage (%) of open arm entriesnd the percentage (%) of time spent on the open arms. The num-
er of closed arm entries was considered as a locomotor measure.
ecreased open arm activities indicate increased anxiety levels in
PM. Between each trial, the maze was wiped clean with a damp
ponge and driedwith paper towels. Before behavioral assessment,i) and of control group in the elevated plus maze. (A) % open arm time; (B) % open
at least ten animals per group. Asterisk(s) indicate statistical differences where
animals were allowed to accommodate to their new environment
for 2 days.
For histological and inﬂammatory analyses the brain tissues of
controls and PbA-infected mice on day 3 and 5 p.i. were removed.
One hemisphere of the brain was homogenized in extraction solu-
tion containing aprotinin and the concentration of the cytokines
IL-1, IL-4, IL-10, TNF- and IFN- was determined by ELISA
(R&D Systems, Minneapolis, MN and Pharmingen, San Diego, CA).
Another hemisphere of the brain was preserved in 10% buffered
formalin. Sections of 5m thick were cut and mounted for routine
haematoxylin and eosin (H&E) staining. These sectionswere exam-
ined at the optical level (Olympus, Japan, JP). Digital images were
acquired for documentation.
Data are shown as mean± SEM. A one-way analysis of vari-
ance (ANOVA) with Tukey’s Multiple Comparison post-test was
used to analyze the brain concentrations of cytokines measured by
ELISA. To analyze the anxiety behavior and locomotor activity in the
EPM the Mann Whitney’s test and the t-student’s test were used,
respectively. All analyses were performed using Prism 4 software
(GraphPad, La Jolla, CA, USA).
CM mice presented a signiﬁcant decrease in the percentage (%)
of time spent on the open arms and in the number of entries into
the open arms when compared to the control animals on day 5 p.i.
(Fig. 1A and B; p≤0.05; n=10 per group). No difference was found
in the number of entries in the closed arms between the infected
mice and controls, indicating that both groups presented similar
locomotor activity in the EPM (Fig. 1C; p=0.12).
No lesions were detected in the brain of non-infected group
and PbA-infected group on day 3 (Fig. 2A, D and G). Infected mice
on day 5 p.i. developed focal meningitis, consisted mainly of lym-
phocytes and macrophages (Fig. 2B). Sequestration of leukocytes
in the microvasculature (vascular plugging) was detected in the
cerebrum, brainstem and hippocampus (Fig. 2C and F). The hip-
pocampus of PbA-infected animals on day 5 p.i. presented various
shrinkage pyramidal neurons in the medial area of CA1 (Fig. 2H).
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ells inﬁltrating the meninges in the cerebrum from PbA-infected. (C) Vascular plug
rea and dentate gyrus. (E) and (H) Note altered CA1 region (asterisk) characterized
he brainstem exhibited multifocal hemorrhages around blood
essels (Fig. 2I).
PbA-infected mice presented higher cerebral levels of IL-1 and
NF-onday5p.i.when comparedwith controls and infectedmice
n day 3 p.i. (Fig. 3; p≤0.05). No signiﬁcant difference was found
n brain levels of IL-4, IL-10 and IFN- between PbA-infected mice
nd controls (Fig. 3).
To the best of our knowledge, this is the ﬁrst study which inves-
igated anxiety-like behavior in CM. We showed that PbA-infected
ice on day 5 p.i. presented anxiety symptoms associated with
ncreased cerebral levels of proinﬂammatory cytokines IL-1 and
NF-, and histopathological changes in the brainstem, cerebrum
nd hippocampus.
Behavioral and cognitive symptoms associated with neuroin-
ammatory processes in CM have been described in experimental
nd clinical studies [7,16,19,27]. Our group has previously demon-
trated that leukocyte recruitment induced by increased levels
f cytokines and chemokines in the brain were associated with
ehavioral and neurological alterations in PbA-infected mice [19].
dditionally, Desruisseaux et al. [7] showed that memory dysfunc-
ion in experimental malaria correlated with brain inﬂammation
nd hemorrhage, and also microglial activation. In PbA infection,-infected mice on day 5 p.i. (B–C, E–F, H–I). (A) Normal histological cerebrum. (B)
arrow heads) in the cerebral cortex. (D) and (G) Hippocampus with preserved CA1
rinkage pyramidal neurons (arrows). (I) Focal microhemorrhage in the brainstem.
TNF- is producedbymicroglia, astrocytes,monocytes andcerebral
vascular endothelium whereas IL-1 is produced by monocytes,
meningeal vascular endothelium and cortical neurons [25]. In a
clinical study with CM children and health controls, John et al. [16]
demonstrated that high levels of TNF- in the cerebrospinal ﬂuid
of CM children correlated with neurological and cognitive deﬁcits
at hospital discharge, 3 and 6 months later. An upregulation of
inﬂammatory cytokines such as IL-1, IL-6 and TNF- has been
alsodescribed in the serumofCMchildren [15,22]. Altogether these
studies suggest that the release of proinﬂammatory mediators in
the CNS may be involved in a wide range of behavioral symptoms
described in murine and human CM.
Some evidence suggests that an overproduction of proinﬂam-
matory cytokines such as IL-1 and TNF- could be involved
in the development of anxiety [1,4,5,17]. Previous works have
demonstrated that systemic (intraperitoneal route) and central
(intracerebroventricular route) administration of IL-1 and TNF-
 in rodents caused a decrease in the percentage of entries and
of time spent on the open arms of the EPM, without a signiﬁ-
cant change of closed-arm entries [1,4,5]. Koo and Duman [17]
measured anxiety behavior using the EPM in rats after infusion
of IL-1 in the lateral ventricle and in mice with a null muta-
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ice on day 3 and 5 post-infection (dpi) and of controls by ELISA. Resultswere expre
ifferences where *p<0.05, **p<0.01.
ion for the IL-1 type I receptor (IL-1RI KO), the primary receptor
or IL-1 in the brain. They found that rats which received the
L-1 infusion presented a decrease in the number of entries in
he open arms whereas the IL-1RI KO mice reduced anxiety-like
ehavior in the EPM as indicated by increased time spent in the
pen arms. It has also been reported that cytokines, especially
L-1, administered systemically or directly into the brain inﬂu-
nce the hypothalamic–pituitary–adrenal (HPA) activity and affect
orepinephrine release at different regions of the brain such as
mygdala and paraventricular nucleus, all ofwhich have been asso-
iated with anxiety [1]. These ﬁndings are in agreement with those
ound in this studyand support an involvementof proinﬂammatory
ytokines in anxiety-like behavior in CM.
This anxiety-like behavior induced by cytokines does not seem
o be speciﬁc for PbA infection. For instance, previous works have
emonstrated that systemic administration of lipopolysaccharide
LPS), a nonspeciﬁc activator of the immune system by inﬂuencing
he release of inﬂammatory cytokines, provokes anxiogenic-like
esponse. It has been shown that mice receiving LPS intraperi-
oneally presented a signiﬁcant decrease in the percentage (%) of
ime spent on the open arms and in the number of entries onto
he open arms of the elevated plus maze, indicating an anxiety-like
ehavior [1,21,29].
It is worth mentioning that only one study have systematically
nvestigated the occurrence of anxiety symptoms in CM patients-10), Th1 (IFN-) and Th2 (IL-4) cytokines concentration in the brain of PbA-infected
s themean± SEM fromat least ﬁve animals per group. Asterisk(s) indicate statistical
[8]. High levels of anxiety and depressionwere described in Ghana-
ian adults with Falciparum malaria infection. Anxiety is probably
underestimated in CM patients since more severe symptoms such
as cognitive andmotor dysfunction are also frequently found in this
condition.
There are some limitations in the present study. The study is
largely descriptive and does not show proof of causality. Other
cytokines may be also involved in anxiety-like behavior. More
studies are needed to describe with more details the anxiety-like
behavior and its association with inﬂammatory changes and brain
damage in CM.
In conclusion, we found that PbA-infected mice presented
anxiety-like behavior symptoms and an increase of proinﬂam-
matory cytokine levels in the brain. These ﬁndings suggest an
involvement of CNS inﬂammatory mediators in anxiety symptoms
found in CM.
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